Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sarpogrelate (MCI-9042) is a new, orally active, specific 5-HT2 receptor antagonist. sarpogrelate increases platelet aggregation, has a haemostatic effect and can be used in the study of berghett's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | Sarpogrelate (MCI-9042) is a new, orally active, specific 5-HT2 receptor antagonist. sarpogrelate increases platelet aggregation, has a haemostatic effect and can be used in the study of berghett's disease. |
Molecular Weight | 429.51 |
Formula | C24H31NO6 |
CAS No. | 125926-17-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sarpogrelate 125926-17-2 inhibitor inhibit